ABN.AS: $40.38 ▲ 0.17 (0.42%)BMPS.MI: $11.57 ▼ -0.15 (-1.30%)BNZL.L: $2,754.00 ▼ -2.00 (-0.07%)DSFIR.AS: $90.76 ▲ 0.88 (0.98%)NESTE.HE: $32.85 ▲ 0.20 (0.61%)REP.MC: $27.99 ▼ -0.15 (-0.53%)SGRO.L: $957.40 ▲ 0.40 (0.04%)CIEN: $395.79 ▲ 3.31 (0.84%)DDOG: $235.62 ▲ 3.07 (1.32%)DELL: $441.98 ▲ 7.20 (1.66%)FTNT: $153.51 ▲ 2.72 (1.80%)HPE: $53.44 ▲ 0.55 (1.04%)MPC: $360.72 ▲ 2.49 (0.70%)PANW: $357.87 ▲ 8.31 (2.38%)CMG: $36.90 ▲ 1.61 (4.56%)DASH: $223.49 ▲ 1.13 (0.51%)MSFT: $483.24 ▲ 2.09 (0.43%)REGN: $834.04 ▲ 7.40 (0.90%)RTX: $209.91 ▼ -2.38 (-1.12%)VLO: $348.86 ▲ 7.35 (2.15%)MU: $966.78 ▼ -7.55 (-0.77%)STX: $850.00 ▼ -0.24 (-0.03%)WDC: $459.44 ▼ -9.61 (-2.05%)AAPL: $309.35 ▼ -1.95 (-0.63%)AMZN: $258.63 ▼ -1.48 (-0.57%)NVDA: $214.72 ▼ -2.13 (-0.98%)ABNB: $187.30 ▲ 2.30 (1.24%)CRWD: $191.95 ▲ 1.61 (0.85%)ACN: $185.28 ▲ 3.93 (2.17%)FCX: $76.67 ▲ 5.45 (7.65%)INTU: $367.00 ▲ 5.13 (1.42%)NEM: $131.58 ▲ 3.94 (3.09%)PLTR: $179.94 ▲ 5.98 (3.44%)ADYEN.AS: $1,074.00 ▲ 11.20 (1.05%)ARGX.BR: $902.00 ▲ 16.80 (1.90%)KRX.IR: $100.60 ▼ -0.10 (-0.10%)SAP.DE: $188.12 ▲ 2.48 (1.34%)VWS.CO: $208.30 ▼ -4.20 (-1.98%)

Company Details

Adicet Bio, Inc.

ACET - NASDAQ

Identifiants & Marche

Ticker ACET
ISIN US0070021086
CIK 0001720580
Bourse NASDAQ
Devise USD

Classification

Secteur Healthcare
Industrie Biotechnology

Entreprise

Pays US
Siege N/A
Fondee N/A
Site Web Lien

Description

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.
Voir l'evolution du cours Retour